University of Edinburgh researchers have developed a new low carbon process to improve the production yield of ultrapure hydrogen from coal-like materials.
The University has licensed a revolutionary technology for remediation of contaminated soil and groundwater to Geosyntec Consultants, Inc., a US-based geo-engineering firm.
An innovative research tool developed at the University is being utilised by a leading research reagent company to create products that will help life scientists to understand Cancer, Rett Syndrome and, possibly, other disorders.
MTEM Ltd became the largest ever spin-out from a Scottish university in 2004 after raising £7.4M to commercialise revolutionary oilfield survey technology and, despite being acquired in 2007, still continues to operate in the Edinburgh region.
When Professor Ken Murray licensed his pioneering Hepatitis B vaccine to a US biotechnology company in the 1980s, no-one could have predicted the global impact of his discovery or the contribution that the royalty income would make to future education and research at the University.